Head-to-head trial reveals better immune-dampening drug for psoriatic arthritis
A newer immune-dampening drug appears to effectively quell pain and swelling in joints affected by psoriatic arthritis, a new study says. The injectable drug bimekizumab (Bimzelx) eased psoriatic arthritis for more patients than a slightly older drug from its same class, risankizumab (Skyrizi), rese
<p>A newer immune-dampening drug appears to effectively quell pain and swelling in joints affected by psoriatic arthritis, a new study says. The injectable drug bimekizumab (Bimzelx) eased psoriatic arthritis for more patients than a slightly older drug from its same class, risankizumab (Skyrizi), rese</p>